Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Background: When judging the success or failure of major lower extremity (MLE) amputation,
the assessment of appropriate functional and quality of life (QOL) outcomes is paramount. The
heterogeneity of the scales and tests in the current literature is confusing and makes it difficult to
compare results. We provide a primer for outcome assessment after amputation and assess the
need for the additional development of novel instruments.
Methods: MEDLINE, EMBASE, and Google Scholar were searched for all studies using functional and QOL instruments after MLE amputation. Assessment instruments were divided into
functional and QOL categories. Within each category, they were subdivided into global and
amputation-specific instruments. An overall assessment of instrument quality was obtained.
Results: The initial search revealed 746 potential studies. After a review of abstracts, 102 were
selected for full review, and 40 studies were then included in this review. From the studies, 21
different assessment instruments were used 63 times. There were 14 (67%) functional measures and 7 (33%) QOL measures identified. Five (36%) of the functional instruments and 3
(43%) of the QOL measures were specific for MLE amputees. Sixteen instruments were used
>1 time, but only 5 instruments were used >3 times. An additional 5 instruments were included
that were deemed important by expert opinion. The 26 assessment instruments were rated.
Fourteen of the best-rated instruments were then described.
Conclusions: The heterogeneity of instruments used to measure both functional and QOL outcomes make it difficult to compare MLE amputation outcome studies. Future researchers should
seek to use high-quality instruments. Clinical and research societies should endorse the best
validated instruments for future use in order to strengthen overall research in the field.
INTRODUCTION
Supported by the Arthur Tracy Cabot Fellowship though the Brigham & Womens Hospital Center for Surgery and Public Health and
the Harvard-Longwood T-32 Vascular Training Grant (to A.T.H.;
NIH 5T32HL007734).
1
Center for Surgery and Public Health, Boston, Massachusetts.
2
Care Act (ACA) establishes the Medicare Shared Savings Program for Accountable Care Organizations
(ACOs) to reduce health care costs and promote
quality.3 One of the main sections, Patient and
Caregiver Experience, includes health and functional status as a key measure for reimbursement.
It is paramount for the vascular specialist to understand how outcomes are assessed.
Unfortunately, the assessment instruments used
to define outcomes are varied and often confusing.4
This review describes the current assessment instruments available for the clinician and identifies areas
for improvement. Because outcomes measure is a
broad topic, this review focuses on functional and
quality of life (QOL) instruments that are most
important to the vascular specialist. Assessment of
function is integral to understanding the effects of
amputation and rehabilitation. QOL is a broader
measure that seeks to provide a singular assessment
of multiple aspects of how a patient views their current health state.
For pre-, peri-, and postoperative planning, it is
important for the vascular specialist to understand
the functional and QOL instruments used to assess
amputees in both the clinical and research realms.
Understanding the instruments used in the literature and selecting the correct instrument to use in
a research project are daunting tasks. Compounding
this is the lack of consensus regarding the criterion
standard measures for both function and QOL.5
We sought to systematically review the current
instruments and perform a needs assessment for
the development of new outcomes instruments.
METHODS
Search
A comprehensive search of MEDLINE, EMBASE,
and Google Scholar was performed with customized
search terms in April 2012. Databases were searched
for clinical studies examining outcome after amputation from January 2001 to March 2012. Key terms
were used, such as lower extremity amputation,
treatment outcomes, assessment instruments, mobility, and quality of life (Appendix I). References
of methodologic studies, existing reviews, and bibliographies of journal articles were also selectively
hand-searched.
Full inclusion and exclusion criteria are available
in Appendix II. The focus was on full-length papers
that used outcome measures to assess an adult, nononcologic amputee population. Studies were not
assessed for quality of the work, because our primary
focus was to determine which assessment
instruments were being used. In addition to instruments identified in the studies, expert opinion was
sought for any other instruments that warranted
discussion.
Existing Reviews
Five previous review articles were identified.
Rommers et al.6 focused on scales and questionnaires regarding patients with MLE amputation.
Gautier-Gagnon and Grise7 developed a handbook
for LEA outcome but did not include walk tests.
Condie et al.5 performed a systematic review of all
instruments to assess lower extremity prosthetics
outcome between 1995 and 2005. Deathe et al.8
reviewed and classified outcome measures according to the World Health Organization (WHO) International Classification of Functioning, Disability and
Health. They focused only on functional outcome
measures. Finally, Sinha and Van Den Heuvel9 performed a systematic review of QOL in lower limb
amputees, focusing on instruments that measure
QOL.9 None of the previous reviews focused on
both function and QOL, and none were written for
an audience of vascular specialists.
Classification and Assessment
Assessment instruments were divided into those
measuring function and QOL. In each category, instruments were again categorized into general and
amputation-specific instruments.10 An overall assessment of instrument quality was performed using
the guidelines suggested by Johnston and Graves.11
Originally designed for use in spinal cord injury, the
guidelines have been previously adapted by Deathe
et al.8 to make them relevant to amputation. Studies
were scored on a 4-point scale for an overall assessment of quality as follows: 4 points (++++) indicated
that the scale was extensively validated, with excellent reliability and validity (i.e., it was very well
established as valid for MLE amputees); 3 points
(+++) indicated that the scale showed content
and metric reliability and validity (i.e., it was
adequately/reasonably valid for the main defined
purpose and could be used in studies, although
checking of assumptions or small improvements
may be desirable to further improve the measure);
2 points (++) indicated that the scale had minimal
validity (i.e., it had apparently applicable content
with good validity/reliability in another group
but little use in MLE amputees, or it was used in
MLE amputees but some limitations were evident
with little reliability/validity information)din these
scales, additional development was desirable, and
the scale could be used if there were no alternatives,
but firm conclusions are not possible given the preliminary and modest degrees of validity evidence;
and 1 point (+) indicated that the scale was questionable or insufficient (i.e., there was little or no
formal validity or reliability evidence and possibly
questionable content for MLE amputees)din these
scales, development would be required in order for
the scale to be applicable to MLE amputees.
Quality was judged independently by all authors,
with group consensus reached only when there was
a discrepancy between evaluators.
RESULTS
The initial search revealed 746 potential studies. After a review of abstracts, 102 were selected for full
review. Of these, another 62 were excluded according to the above exclusion criteria. Forty studies
were then included in this review (Appendix III).
From the studies, 21 different assessment instruments were used 63 times (Table 1). There were 14
(67%) functional measures and 7 (33%) QOL measures identified. Five (36%) of the functional instruments and 3 (43%) of the QOL measures were
specific for MLE amputees. Sixteen instruments
were used >1 time, including the Short Form-36
General Health Status Survey (SF-36)/Short Form12 General Health Status Survey (SF-12; 13 times),
the Prosthetic Evaluation Questionnaire (5 times),
the 6-Minute Walk Test/2-Minute Walk Test
(6MWT/2MWT; 5 times), the Timed Up and Go
(TUG; 4 times), the Functional Independence Measure (4 times), the modified Barthel Index (3 times),
the Frenchay Activity Index (FAI; 3 times), the
Locomotor Capabilities Index (3 times), the Houghton Scale (3 times), the WHOQOL-100/short version of the WHOQOL (WHOQOL-BREF; 3 times),
the Simple Walking test (2 times), the Sickness
Impact Profile (2 times), the Special Interest Group
in Amputee Medicine assessment (SIGAM; 2 times),
the Nottingham Health Profile (2 times), the European QOL scale (EQ5D; 2 times), and the Trinity
Amputation and Prosthesis Experiences Scales
(2 times). A number of studies not included in this
review used original, nonvalidated assessment
instruments. The examination of previous review
papers and discussions with expert consultants
resulted in an additional 5 instruments included
for description, for a total of 26 instruments
(Table II). After rating, 14 instruments were graded
as +++ or above. They are described below, along
with studies that exemplify their usage. Descriptions
of the remaining 12 instruments can be found in
Appendix IV.
Table I. List of instruments by function versus quality of life and then by general versus amputee-specific
Instrument
Rating
Tests of function
General tests
Walking tests
Six-minute Walk Test (6MWT)
Timed Up and Go (TUG)
10 m Walk
Simple Walking
General function
Activities of daily living
Frenchay Activity Index (FAI)
Modified Barthel Index (BI)
Functional Independence Measure (FIM)
International Physical Activity Questionnaire (IPAQ)
Sickness Impact Profile (SIP)
Mobility
Rivermead Mobility Index (RMI)
Amputee-specific
Special Interest Group in Amputee Medicine (SIGAM)
Houghton Scale
Locomotor Capabilities Index (LCI-5)
Questionnaire for Persons with a Transfemoral Amputation (Q-TFA)
Prosthetic Profile of the Amputee (PPA)
Days Amputee Activity Score (AAS)
Amputee Mobility Predictor (AMP)
Functional Measure for Amputees (FMA)
Test of quality of life
General
Short Form 36- General Health Status Survey (SF-36)
Short Form 12- General Health Status Survey (SF-12)
World Health Organization Quality of Life Assessment Instrument 100 (WHOQOL-100)
European Quality of Life (EQ5D)
Nottingham Health Profile (NHP)
Satisfaction with Life Scale (SWLS)
Amputee-specific
Prosthesis Evaluation Questionnaire (PEQ)
Trinity Amputation and Prosthesis Experiences Scales (TAPES)
Attitude to Artificial Limb Questionnaire (AALQ)
+++
+++
+++
+
+++
++
++
++
++
+++
+++
+++
+++
++
++
++
++
++
++++
+++
++++
++++
+++
++
+++
++
+
Instruments of Function:
Amputee-Specific
The SIGAM (+++) test is a single-item scale
comprising 6 clinical grades (AeF) of amputee
mobility.30 Grades range from A (nonlimb user) to
F (normal or near normal walking). SIGAM was
based on the Harald Wood Stanmore observer rated
measure.31 The test is a self-report questionnaire
answered yes/no that then uses an algorithm to
facilitate grade assignment. Reliability is excellent,
but there are sparse data to determine validity.32
Test
First author
Year of
publication Domains
Items
Time to
perform
(min)
Functiondgeneral
6MWT/2MWT
TUG
10-m walk
FAI
d
d
d
Holbrook
d
d
d
1983
d
d
d
3
d
d
d
15
10/5
1e10
0eN min
5
RMI
Franchignoni 2003
14 questions
10
plus standing
Yes
Free
Validated in
amputee?
Cost
Yes
Yes
Yes
No
Free
Free
Free
Free
Scoring range
0eN m
0eN min
0eN min
15e60, with 60 representing
the highest level of activity
0 (poor mobility) to 15
(excellent mobility)
Functiondamputee-specific
SIGAM
Ryall
2003
21
Yes
Free
Houghton scale
Houghton
1992
Yes
Free
LCI-5
Franchignoni 2004
14
Yes
Free
1992
36
10e15
No
SF-12
Ware
1996
12
2e3
No
EQ5D
Euro QOL
1990
5 + VAS 5 + VAS
No
WHOQOL-100/BREF WHOQOL
Group
1994
6/4
100/26
20e30/10 No
NHP
1990
45
5e10
No
1998
82
10
Yes
Hunt
Quality of lifedamputee-specific
PEQ
Legro
Free
+++
+++
+++
+++
+++
+++
AeF (ranging from A
[nonlimb user] to F
[normal or near normal
walking])
0e12 (12 represents excellent +++
performance)
0e56, with 56 being the best +++
possible
++++
+++
++++
++++/+++
+++
+++
6MWT/2MWT, 6-min walk test/2-min walk test; EQ5D, European Quality of Life; FAI, Frenchay Activity Index; MET, metabolic equivalent; NHP, Nottingham Health Profile; LCI-5,
Locomotor Capabilities Index; PEQ, Prosthesis Evaluation Questionnaire; RMI, Rivermead Mobility Index; SF-12, Short-Form 12; SF-36, Short-Form 36; SIGAM, Special Interest
Group in Amputee Medicine; TUG, Timed Up and Go; VAS, Visual Analog Scale; WHOQOL-100, World Health Organization Quality of Life Assessment 100.
Quality of lifedgeneral
SF-36
Ware
Overall quality
(adapted from
Johnston and
Graves11)
Table II. Summary including test, first author, domains, items, time to perform, and scoring range
Met et al.33 used the SIGAM to show that it is preferable to perform a straight above the knee amputation (AKA) instead of a through the knee
amputation if the correct amputation level is in
doubt in high-risk patients.
The Houghton Scale (+++) was originally described in a vascular amputee population.34,35 It is
a self-reported assessment of performance comprised of 4 sections. The test quantifies prosthetic
use by time, context, ambulatory aids, and confidence over variable terrain. It is designed to assess
activities that are independent of age, sex, gait quality, and comorbidities. The first 3 categories are
measured on a 4-point scale, and the last has 3 questions with yes/no answers. The total score is on a
12-point scale; a higher score indicates better performance. The Houghton Scale has high reliability and
is appropriately responsive to change in prosthetic
use in individuals with lower-limb amputation after
rehabilitation.36 The Houghton Scale has been used
by Bhangu et al.37 to show that the overall functional outcome of individuals with a combination
of below the knee amputation (BKA) and AKA
because of dysvascular causes is poor, with a low
level of ambulation, activity, and prosthetic use.
The Locomotor Capabilities Index (LCI; +++) is a
stand-alone subset of the Prosthetic Profile of the
Amputee (PPA). It was designed to trace a comprehensive profile of ambulatory skills of the lower
limb amputee with the prosthesis and to evaluate
their level of independence while performing these
activities.38 Like the PPA, it is self-reported and
comprised of 4-point ordinal scales and provides
an aggregated score for the 14 items. Franchignoni
et al.39 transformed the original scale of the LCI
into a 5-level version, the LCI-5. The upper ordinal
level of each LCI item Yes, alone was split into
2 levels: Yes, alone, with ambulation aids (score:
3 points) and Yes, alone, without ambulation
aids (score: 4 points). Therefore, the total score of
the index is 56, with maximum subscores of 26.
The test is widely used, with good consistency, reliability, and validity.40e42 Ceiling effects have been
reduced by 50% in the LCI-5.40 Traballesi et al.43
used the LCI-5 to show that age reduced the possibility of improving the level of autonomy and that
good stump quality is one of the major determinants
of mobility outcome.
Instruments of Quality of Life: General
The SF-36 (also known as the MOS-36; ++++) was
developed by the medical outcomes study as an
instrument for both clinical assessment and research.44 It contains 8 domains: physical, role and
physical mobility, and pain). The second session addresses difficulty with ADLs with 7 yes/no questions
(i.e., employment, housework, family relationships,
social life, sex life, hobbies, and vacations). Scores
range from 0e100, with a higher score indicating a
poorer level of health. The test has been translated
into many languages. The original papers describe
high reliability and validity. The NHP was used by
Demet et al.54 to show that young age at the time
of amputation, traumatic origin, and upper limb
amputation were independently associated with
better QOL.
Instruments of Quality of Life: Amputee
Specific
The Prosthetics Evaluation Questionnaire (PEQ;
+++) was developed from 1995e1997 to fill the
need for a comprehensive self-report instrument
for individuals with lower limb loss who use a prosthesis.55 The PEQ is a self-administered questionnaire consisting of 82 items with a linear analog
scale response format. Nine scales are computed
from 42 items (i.e., ambulation, appearance, frustration, perceived response, residual limb health, social
burden, sounds, utility, and well-being). Scales are
reported with a range from 0e100, with 100 representing the best score possible. The PEQ has good
reliability and good to excellent construct validity.55,56 Pinzur et al.57 used the PEQ to show that patients with bone bridging had scores better than or
comparable to those of a selected group of highly
functional traditional BKAs.
DISCUSSION
While there is no criterion standard available for
outcome measures, there are a number of validated
instruments that are of high quality and are widely
used. We found that a wide range of outcome assessment instruments are available to both the researcher and clinician. While the large choice of
potential instruments to fit to the particular study
question is useful, the heterogeneity of the tests
means that it is difficult to compare results from
study to study.
Identifying the perfect universal functional and
QOL instrument is difficult for 2 reasons. First,
each instrument has its strengths and weakness.
Some trade brevity for comprehensiveness; others
aim for generalizability across disease states rather
than amputee specificity. Second, each research
study or clinical practice has its own specific goals
and needs. However, there are certain instruments
in each category that are easy to administer, have
Table III. A guide to the selection of functional and quality of life assessment instruments for amputees
Time (min)
Setting
Use
Test
Functiondgeneral
6MWT/2MWT
TUG
10 M WALK
FAI
RMI
Functiondamputeespecific
SIGAM
Houghton scale
LCI-5
Quality of lifedgeneral
SF-36
SF-12
EQ5D
WHOQOL-100
NHP
Quality of lifed
amputee-specific
PEQ
N/A
N/A
N/A
English, Dutch, and
Chinese
English, Italian, and
Dutch
Mode of
administration
Observation
Observation
Observation
Questionnaire
Questionnaire/
observational
>50
>50
>150
>20
19
Questionnaire
Questionnaire
Questionnaire
Questionnaire
Questionnaire
Questionnaire
English
Questionnaire
English
Questionnaire
Dutch, English, French, Questionnaire
Italian, Portuguese,
Spanish, and Swedish
6MWT/2MWT, 6-min walk test/2-min walk test; EQ5D, European Quality of Life; FAI, Frenchay Activity Index; MET, metabolic
equivalent; NHP, Nottingham Health Profile; LCI-5, Locomotor Capabilities Index; PEQ, Prosthesis Evaluation Questionnaire; RMI,
Rivermead Mobility Index; SF-12, Short-Form 12; SF-36, Short-Form 36; SIGAM, Special Interest Group in Amputee Medicine;
TUG, Timed Up and Go; VAS, Visual Analog Scale; WHOQOL-100, World Health Organization Quality of Life Assessment 100.
2.
3.
4.
5.
CONCLUSION
The heterogeneity of methods used to measure both
functional and QOL outcomes makes it difficult to
compare MLE amputation outcome studies. Future
researchers should seek to use well-established instruments. Clinical and research societies should
endorse the best validated instruments for future
use to strengthen overall research in the field.
6.
7.
8.
REFERENCES
9.
1. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, et al.
Estimating the prevalence of limb loss in the United
10. Mays RJ, Casserly IP, Kohrt WM, et al. Assessment of functional status and quality of life in claudication. J Vasc Surg
2011;53:1410e21.
11. Johnston MV, Graves DE. Towards guidelines for evaluation
of measures: an introduction with application to spinal cord
injury. J Spinal Cord Med 2008;31:13e26.
12. Schoppen T, Boonstra A, Groothoff JW, et al. The timed up
and go test: reliability and validity in persons with unilateral lower limb amputation. Arch Phys Med Rehabil 1999;
80:825e8.
13. Schoppen T, Boonstra A, Groothoff JW, et al. Physical,
mental, and social predictors of functional outcome in unilateral lower-limb amputees. Arch Phys Med Rehabil
2003;84:803e11.
14. Boonstra AM, Fidler V, Eisma WH. Walking speed of normal
subjects and amputees: aspects of validity of gait analysis.
Prosthet Orthot Int 1993;17:78e82.
15. Munin MC, Espejo-De Guzman MC, Boninger ML, et al.
Predictive factors for successful early prosthetic ambulation
among lower-limb amputees. J Rehabil Res Dev 2001;38:
379e84.
16. Brooks D, Hunter JP, Parsons J, et al. Reliability of the twominute walk test in individuals with transtibial amputation.
Arch Phys Med Rehabil 2002;83:1562e5.
17. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines
for the six-minute walk test. Am J Respir Crit Care Med
2002;166:111e7.
18. Collin C, Wade D, Cochrane G. Functional outcome of lower
limb amputees with peripheral vascular disease. Clin Rehabil 1992;6:13e21.
19. Datta D, Ariyararatnam R, Hilton S. Timed walking testdan
all-embracing outcome measure for lower-limb amputees?
Clin Rehabil 1996;10:227.
20. Rau B, Bonvin F, de Bie R. Short-term effect of physiotherapy rehabilitation on functional performance of lower
limb amputees. Prosthet Orthot Int 2007;31:258e70.
21. Holbrook M, Skilbeck CE. An activities index for use with
stroke patients. Age Ageing 1983;12:166e70.
22. Wade DT, Legh-Smith J, Langton Hewer R. Social activities
after stroke: measurement and natural history using the
Frenchay activities index. Int Rehabil Med 1985;7:176e81.
23. Schuling J, de Haan R, Limburg M, et al. The Frenchay
Activities Index. Assessment of functional status in stroke
patients. Stroke 1993;24:1173e7.
24. Schepers VP, Ketelaar M, Visser-Meily JM, et al. Responsiveness of functional health status measures frequently
used in stroke research. Disabil Rehabil 2006;28:1035e40.
25. Green J, Forster A, Young J. A test-retest reliability study of
the Barthel Index, the Rivermead Mobility Index, the Nottingham Extended Activities of Daily Living Scale and the
Frenchay Activities Index in stroke patients. Disabil Rehabil
2001;23:670e6.
26. Miller WC, Deathe AB, Harris J. Measurement properties of
the Frenchay Activities Index among individuals with a
lower limb amputation. Clin Rehabil 2004;18:414e22.
27. Asano M, Rushton P, Miller WC, et al. Predictors of quality
of life among individuals who have a lower limb amputation. Prosthet Orthot Int 2008;32:231e43.
28. Franchignoni F, Brunelli S, Orlandini D, et al. Is the Rivermead Mobility Index a suitable outcome measure in lower
limb amputees?dA psychometric validation study. J Rehabil Med 2003;35:141e4.
29. Forlander DA, Bohannon RW. Rivermead mobility index: a
brief review of research to date. Clin Rehabil 1999;13:97e100.
30. Ryall NH, Eyres SB, Neumann VC, et al. The SIGAM
mobility grades: a new population-specific measure for
lower limb amputees. Disabil Rehabil 2003;25:833e44.
31. Hanspal RS, Newman WP. Mobility grades in amputee rehabilitation. Clin Rehabil 1991;5:344.
32. Gardiner MD, Faux S, Jones LE. Inter-observer reliability of
clinical outcome measures in a lower limb amputee population. Disabil Rehabil 2002;24:219e25.
33. Met R, Janssen LI, Wille J, et al. Functional results after
through-knee and above-knee amputations: does more length
mean better outcome? Vasc Endovascular Surg 2008;42:
456e61.
34. Houghton A, Allen A, Luff R, et al. Rehabilitation after
lower limb amputation: a comparative study of aboveknee, through-knee and Gritti-Stokes amputations. Br J
Surg 1989;76:622e4.
35. Houghton AD, Taylor PR, Thurlow S, et al. Success rates for
rehabilitation of vascular amputees: implications for preoperative assessment and amputation level. Br J Surg 1992;
79:753e5.
36. Devlin M, Pauley T, Head K, et al. Houghton scale of prosthetic use in people with lower-extremity amputations: reliability, validity, and responsiveness to change. Arch Phys
Med Rehabil 2004;85:1339e44.
37. Bhangu S, Devlin M, Pauley T. Outcomes of individuals
with transfemoral and contralateral transtibial amputation
due to dysvascular etiologies. Prosthet Orthot Int 2009;33:
33e40.
38. Gauthier-Gagnon C, Grise MC. Prosthetic profile of the
amputee questionnaire: validity and reliability. Arch Phys
Med Rehabil 1994;75:1309e14.
39. Streppel KR, de Vries J, van Harten WH. Functional status
and prosthesis use in amputees, measured with the Prosthetic Profile of the Amputee (PPA) and the short version
of the Sickness Impact Profile (SIP68). Int J Rehabil Res
2001;24:251e6.
40. Franchignoni F, Orlandini D, Ferriero G, et al. Reliability,
validity, and responsiveness of the locomotor capabilities index in adults with lower-limb amputation undergoing prosthetic training. Arch Phys Med Rehabil 2004;85:743e8.
41. Miller WC, Deathe AB, Speechley M. Lower extremity prosthetic mobility: a comparison of 3 self-report scales. Arch
Phys Med Rehabil 2001;82:1432e40.
42. Gauthier-Gagnon C, Grise M, Lepage Y. The locomotor
capabilities index: content validity. J Rehabil Outcomes
Measurement 1998;4:40e6.
43. Traballesi M, Porcacchia P, Averna T, et al. Prognostic factors
in prosthetic rehabilitation of bilateral dysvascular aboveknee amputee: Is the stump condition an influencing factor?
Eura Medicophys 2007;43:1e6.
44. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form
health survey (SF-36). I. conceptual framework and item
selection. Med Care 1992;30:473e83.
45. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form
health survey: construction of scales and preliminary tests
of reliability and validity. Med Care 1996;34:220e33.
46. Penn-Barwell JG. Outcomes in lower limb amputation
following trauma: a systematic review and meta-analysis.
Injury 2011;42:1474e9.
47. EuroQol Group. EuroQolda new facility for the measurement of health-related quality of life. Health Policy 1990;
16:199e208.
48. Chilcott J, McCabe C, Tappenden P, et al. Modelling the cost
effectiveness of interferon beta and glatiramer acetate in the
management of multiple sclerosis. Commentary: evaluating
49.
50.
51.
52.
53.
APPENDIX
CRITERIA
II:
INCLUSION/EXCLUSION
Inclusion criteria
Major lower extremity amputee population
Full paper
Written in English
Sample size
(amputees only) Country
Population (etiology)
Eijk et al (2012)29
48
Netherlands BI
Cox et al (2011)30
87
Jamaica
WHOQOL-BREF and
FIM
Frlan-Vrgoc et al (2011)31
50
Croatia
2MWT
da Silva et al (2011)32
MLE amputees
22
Brazil
MLE amputees
20
Australia
Sinha et al (2011)34
MLE amputees
184
Penn-Barwell (2011)35
Mazari et al (2010)36
BKA amputees
Stineman et al (2010)37
Raya et al (2010)38
Assessment instruments
Netherlands SF-36
3,105
UK
29
UK
US
FIM
US
6MWT
Outcomes
Table.
Sample size
(amputees only) Country
Population (etiology)
Remes et al (2010)39
59
Davidson et al (2010)40
MLE amputees
39
Taghipour et al (2009)41
Giannoudis et al (2009)42
Assessment instruments
Outcomes
Finland
SF 36 and SWLS
Australia
SF-36
141
Iran
SF-36
22
UK
EQ5D
1,339
US
FIM
MLE amputees
Bhangu et al (2009)44
31
Canada
2MWT, Houghton
scale, and FAI
Boutoille et al (2008)45
25
France
SF-36
82
Canada
SF-12
415
Canada
MacNeill et al (2008)46
Asano et al (2008)47
MLE amputation
Kurichi et al (2009)43
Table. Continued
75
Desmond et al (2008)49
MLE amputation
89
Johannesson et al (2008)50
27
Met et al (2008)51
50
Stasik et al (2008)52
23
Yazicioglu et al (2007)53
24
49
Traballesi et al (2006)57
Rau et al (2007)54
Pinzur et al (2006)55
58
601
30
UK
MLE amputees
Deans et al (2008)48
Sample size
(amputees only) Country
Population (etiology)
Gunawardena et al (2006)58
461
Sri Lanka
213
Malaysia
Meatherall et al (2005)60
44
BKA amputees
281
Schoppen et al (2003)64
46
Demet et al (2003)65
Canada
220
Netherlands
26
Netherlands
UK
Netherlands
539
France
437
Netherlands
MLE amputees
75
US
43
Netherlands
Outcomes
SF-36
AKA, Above-knee amputation; BKA, below-knee amputation; BTTA, bilateral trans tibial amputation; CLI, critical limb ischemia; DM, diabetes mellitus; MLE, major lower extremity;
PVD, peripheral vascular disease; TKA, trans-knee amputation; UK, United Kingdom; US, United States.
Dysvascular includes both PVD and DM.
Munin et al (2001)67
Assessment instruments
Table. Continued
Exclusion criteria
Amputations caused by oncologic or congenital
etiologies
Pediatric populations
Review papers
The International Physical Activity Questionnaire (IPAQ; ++) is designed to provide a set of
well-developed instruments that can be used
internationally to obtain comparable estimates of
physical activity.8 There are 2 versions of the
questionnaire, and each has been translated into
22 languages. The short version (7 questions) is
suitable for use in national and regional surveillance systems, whereas the long version (27 questions over 5 domains) provides more detailed
information often required in research work or
for evaluation purposes. Results are reported
both as categorical (i.e., low, moderate, and high
physical activity) and continuous (median metabolic equivalent of a task minutes). The IPAQ
has been extensively validated among a number
of different groups, but has seen little use in
amputee populations.9e12
The Sickness Impact Profile (SIP; ++) is a
136-question, behaviorally based health status
questionnaire.13,14 It assesses activities in 2 domains
(physical and psychological health) and 12 everyday
categories (i.e., sleep and rest, emotional behavior,
body care and movement, home management,
mobility, social interaction, ambulation, alertness
behavior, communication, work, recreation and
pastimes, and eating). The test is administered by
either a questionnaire or by an interviewer (training
is required). Scoring can be done at the level of domains and/or categories and at the total SIP level.
Higher scores indicate more health-related behavioral problems (i.e., a poorer health state). The SIP
has well documented reliability and validity.15,16
Scaled down versions are also available, most
notably the SIP-68.17
Instruments of Function: Amputee-Specific
The Questionnaire for Persons with a Transfemoral Amputation (Q-TFA; ++) is a self-reported,
70-question measure developed for nonelderly
transfemoral amputees who use a prosthesis.18 The
test generates a separate score (range: 0e100) for 4
categories: prosthetic use, mobility, problems, and
global health. Scores of 100 indicate normal prosthesis wear, best possible mobility, more serious
problems, and the best possible overall situation,
respectively. The Q-TFA is a very specific survey
for patients with an above the knee amputation
who wear a prosthesis.
The Prosthetic Profile of the Amputee (PPA; ++) is
an instrument to evaluate prosthetic wear and
active use of the prosthesis and to identify the factors
that predispose to, enable, and reinforce prosthetic
use.19,20 The PPA questionnaire consists of 44
Appendix References
1. Mahoney FI, Barthel DW. Functional evaluation: the Barthel
index. Md State Med J 1965;14:61e5.
2. Treweek SP, Condie ME. Three measures of functional
outcome for lower limb amputees: a retrospective review.
Prosthet Orthot Int 1998;22:178e85.
3. Keith RA, Granger CV, Hamilton BB, et al. The functional independence measure: a new tool for rehabilitation. Adv Clin
Rehabil 1987;1:6e18.
4. Granger CV, Hamilton BB, Keith RA, et al. Advances in functional assessment for medical rehabilitation. Top Geriatr
Rehabil 1986;1:59e74.
5. Hamilton BB, Laughlin JA, Fiedler RC, et al. Interrater reliability of the 7-level functional independence measure
(FIM). Scand J Rehabil Med 1994;26:115e9.
6. Stineman MG, Shea JA, Jette A, et al. The functional independence measure: tests of scaling assumptions, structure,
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.